The desire for patients to have a personalized approach to care is repeated throughout the ad, which was produced by Avalere ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

The Food and Drug Administration (FDA) has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are ...

"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...